83 research outputs found

    Sympatric speciation

    Get PDF

    Evolution of Protein Expression: New Genes for a New Diet

    Get PDF
    SummaryA new study identifies gene duplication of a salivary enzyme as a recent adaptation to changes in diet among human populations, highlighting the diverse ways that gene regulation can evolve

    Inclusive fitness theory and eusociality

    Get PDF

    Especiação e seus mecanismos: histórico conceitual e avanços recentes

    Full text link

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    More Crank Science

    Full text link
    Jest to recenzja ksiÄ…ĆŒki Michaela J. Behe'ego Darwin's Black Box: The Biochemical Challenge to Evolution (The Free Press, New York 1996). Coyne stara się juĆŒ z gruntu metodologicznego zdyskredytować teorię inteligentnego projektu, ktĂłrej Behe jest zwolennikiem. UwaĆŒa tę teorię za nienaukową, gdyĆŒ - jego zdaniem - nie da się jej sfalsyfikować. Co więcej, twierdzi, iĆŒ jest ona przejawem „fanatyzmu w nauce" - moĆŒna ją traktować na rĂłwni z homeopatią czy teorią spolimeryzowanej wody.It is a review of Michael J. Behe’s book titled Darwin’s Black Box: The Biochemical Challenge to Evolution (The Free Press, New York 1996), containing the criticism of evolutionary theory. Author tries to discredit intelligent design theory, of which Behe is a proponent, on methodological grounds. According to the author, it is unscientific theory because it cannot be falsified. Moreover, in his opinion, it is an manifestation of „crank science” – it can be treated in the same way as homeopathy or polywater theory

    Ernest Mayr (1904-2005)

    Full text link
    • 

    corecore